- Home
- FGL vs INKT Comparison
FGL vs INKT Comparison
Compare FGL & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- INKT
- Stock Information
- Founded
- FGL 2021
- INKT 2017
- Country
- FGL Malaysia
- INKT United States
- Employees
- FGL N/A
- INKT N/A
- Industry
- FGL
- INKT Medicinal Chemicals and Botanical Products
- Sector
- FGL
- INKT Health Care
- Exchange
- FGL NYSE
- INKT Nasdaq
- Market Cap
- FGL 25.4M
- INKT 75.7M
- IPO Year
- FGL 2024
- INKT 2021
- Fundamental
- Price
- FGL $1.21
- INKT $16.54
- Analyst Decision
- FGL
- INKT Hold
- Analyst Count
- FGL 0
- INKT 3
- Target Price
- FGL N/A
- INKT $37.50
- AVG Volume (30 Days)
- FGL 345.2K
- INKT 3.0M
- Earning Date
- FGL 08-05-2025
- INKT 08-12-2025
- Dividend Yield
- FGL N/A
- INKT N/A
- EPS Growth
- FGL N/A
- INKT N/A
- EPS
- FGL N/A
- INKT N/A
- Revenue
- FGL $20,205,441.00
- INKT N/A
- Revenue This Year
- FGL N/A
- INKT N/A
- Revenue Next Year
- FGL N/A
- INKT N/A
- P/E Ratio
- FGL N/A
- INKT N/A
- Revenue Growth
- FGL N/A
- INKT N/A
- 52 Week Low
- FGL $0.66
- INKT $4.56
- 52 Week High
- FGL $5.26
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- INKT 49.27
- Support Level
- FGL N/A
- INKT $16.02
- Resistance Level
- FGL N/A
- INKT $20.25
- Average True Range (ATR)
- FGL 0.00
- INKT 8.31
- MACD
- FGL 0.00
- INKT -1.23
- Stochastic Oscillator
- FGL 0.00
- INKT 0.86
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.